Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0080
-0.0004
(-4.76%)
At close: February 27 at 3:00:00 PM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Ms. Saundra Pelletier | Interim Chair, President & CEO | 1.52M | -- | 1970 |
Ms. Ivy Zhang CPA | CFO & Secretary | 438.85k | -- | 1978 |
Ms. Ellen Thomas | Chief of Staff | -- | -- | -- |
Ms. Amy Raskopf | Chief Business Development Officer | -- | -- | -- |
Ms. Kathy Gallo-Doyle | Senior Vice President of Commercial Operations | -- | -- | -- |
Evofem Biosciences, Inc.
7770 Regents Roas
Suite 113-618
San Diego, CA 92122
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 37
Description
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Corporate Governance
Evofem Biosciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 25, 2025 at 12:30 PM UTC - March 31, 2025 at 12:30 PM UTC
Evofem Biosciences, Inc. Earnings Date
Recent Events
Related Tickers
APLIF Appili Therapeutics Inc.
0.0250
-7.41%
ENDV Endonovo Therapeutics, Inc.
0.0002
0.00%
TSOI Therapeutic Solutions International, Inc.
0.0003
0.00%
ADTX Aditxt, Inc.
0.0693
-13.37%
BIXT Bioxytran, Inc.
0.0763
+7.31%
TNFA TNF Pharmaceuticals, Inc.
0.4297
-2.21%
ONCO Onconetix, Inc.
0.3068
-4.12%
CNBX CNBX Pharmaceuticals Inc.
0.0100
-11.50%
OMGAQ
0.0310
-46.55%
ELAB PMGC Holdings Inc.
1.1900
-4.80%